Report Categories
View AllRecent Articles
View All
Berkshire Hathaway Returns to Skies with 26 Billion Delta Air Lines Stake
BP Ousts Chair Albert Manifold Amid Governance Concerns
Spotify CEO Defends AI Music Feature Positioning It as Alternative to Piracy and Unregulated Slop
Mercury Reaches 52 Billion Valuation in Latest Funding Round Defying Fintech Downturn
Memorial Day 2026 Stock Market Closure and Holiday Trading Schedule
CE Q1 2026 Earnings EPS Misses Estimates by 46 Stock Gains 107
Hyperfine Inc HYPR Q1 2026 Earnings EPS Surprises to the Upside Stock Jumps 11
WSBCO Q1 2026 Earnings Preferred Stock Series B Beats EPS Estimates Amid Stable Operations
City Holding Company CHCO Q1 2026 Earnings Narrow EPS Beat Supports Modest Stock Gain
GWH Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Stage
Mueller Water Products MWA Edges Higher as Support Holds Steady
UFP Technologies UFPT Holds Above Support After Modest Decline Focus Shifts to Resistance
Elicio Therapeutics ELTX Holds Near Resistance as Therapeutic Pipeline Momentum Builds
Humacyte Inc HUMA Gains 36 as Stock Approaches Key Resistance Level
PutinXi Talks Rekindle Stalled Power of Siberia 2 Pipeline as Iran Conflict Shakes Energy Markets
Nvidias Annual Spending on Taiwan AI Suppliers Could Reach 150 Billion Jensen Huang States
Reddit Shares Decline Nearly 6 Following Metas Launch of Forum App
April Jobs Report Expected to Show Cooling Yet Resilient Labor Market
External Links
Morgan Stanley Adjusts Home Depot Price Target Lower by 20
BJ Q1 2026 Earnings EPS Beats Estimates Despite Stock Decline
JACK Q1 2026 Earnings EPS Slightly Misses Estimates but Stock Surges Over 8
CV Q1 2026 Earnings EPS Misses Estimates by 12 Stock Declines Nearly 2
IMKTA Q1 2026 Earnings Solid EPS of 128 Amid Modest Market Reaction
BBB Foods Inc TBBB Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Quarter
CAE Q1 2026 Earnings EPS Beat of 122 Amid Stock Decline
Orion Properties Inc ONL Q1 2026 Earnings Deep EPS Miss Weighs on Results as Stock Holds Steady
VOYA Q1 2026 Earnings EPS Surpasses Estimates by 8 Amid Solid Underwriting and Fee Income
LIXT Q4 2024 Earnings ClinicalStage Biotech Reports perShare Loss as Development Continues